Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics Expands Distribution Agreement with Canada s UBI: May 25, 2004 (rev. 2)

This article has been updated to include details on the expanded agreement.

 

NEW YORK, May 25 (GenomeWeb News) - Strand Genomics of Bangalore, India, has expanded its distribution agreement with Canada-based UBI for its Avadis software, the company said today.

 

Strandsaid that it originally signed a distribution agreement with UBI in late 2003 for its Acuris genome annotation software. The deal -- a non-exclusive distribution agreement for Canada-- was extended to include Avadis last month.

 

Avadis is a microarray gene expression analysis tool.

 

UBI, based in Calgary, specializes in distributing bioinformatics software.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.